Select committee: Science and Technology Committee
Innovation in the NHS: personalised medicine and AI
Open
Opened 3 Mar 2026
Science and Technology Committee Inquiry on parliament.uk ↗
Inquiry scope (the committee's words)
Advances in artificial intelligence and genomics offer the prospect of developing truly personalised medicine across prevention, diagnosis, and treatment. Our inquiry will seek to use this as an example to explore a broader question: why does the NHS adoption of the UK’s cutting-edge life sciences innovations often fail, and what could be done to fix it?
Where it stands
The inquiry is open, opened 3 March 2026.
The committee has not published a report yet.
Evidence
- 12 oral evidence sessionsLatest 7 July 2026
- 33 witnesses
Recent activity
- Oral evidence session7 July 2026, Oral evidence
- Oral evidence session30 June 2026, Oral evidence
- Oral evidence session24 June 2026, Oral evidence
Oral evidence sessions
On smaller screens, scroll horizontally to read every column. Keyboard users can focus the table region and use the arrow keys.
| Date | Session and witnesses | Source |
|---|---|---|
| 7 Jul 2026 |
Oral evidence session
Fiona Bride · Department of Health and Social Care (DHSC),
Preet Kaur Gill MP · Department of Health and Social Care (DHSC),
Rob Thompson · Department of Health and Social Care (DHSC)
|
View ↗ |
| 30 Jun 2026 |
Oral evidence session
Lawrence Tallon · Medicines and Healthcare products Regulatory Agency (MHRA)
|
View ↗ |
| 24 Jun 2026 |
Oral evidence session
Dr Valerie Crolley · Royal Free NHS Foundation Trust,
Professor Jonathan Benger CBE · NICE (National Institute for Health and Care Excellence),
Professor Nick Turner · The Royal Marsden NHS Foundation Trust
|
View ↗ |
| 16 Jun 2026 |
Oral evidence session
Dr Bernie Croal · The Royal College of Pathologists,
Dr Pritesh Mistry · The Kings Fund,
Dr Stephen Harden · The Royal College of Radiologists (RCR),
Professor Ben Bridgewater · Health Innovation Network
|
View ↗ |
| 9 Jun 2026 |
Oral evidence session
Professor Andrew Beggs · University of Birmingham,
Professor Mikael Sodergren · Imperial College London,
Roland Sinker CBE · Cambridge University Hospitals Trust (2015-2025)
|
View ↗ |
| 2 Jun 2026 |
Oral evidence session
Dr Melanie Ivarsson · Health Data Research Service (HDRS),
The Baroness Blackwood of North Oxford · Health Data Research Service (HDRS)
|
View ↗ |
| 19 May 2026 |
Oral evidence session
Dr Christian Itin · Autolus Therapeutics,
Dr Michalis Papadakis · Brainomix,
Dr Phil L'Huillier · Scancell,
Professor Peter Donnelly · Genomics Ltd
|
View ↗ |
| 21 Apr 2026 |
Oral evidence session
Professor Dame Sue Hill,
Professor Raghib Ali OBE · Our Future Health,
Professor Sir Rory Collins FRS, FMedSci, FRCP · UK Biobank
|
View ↗ |
| 14 Apr 2026 |
Oral evidence session
Professor Andrew Morris,
Professor Cathie Sudlow
|
View ↗ |
| 24 Mar 2026 |
Oral evidence session
Chris Molloy · Medicines Discovery Catapult,
Matthew Durdy · Cell and Gene Therapy Catapult,
Professor Anneke Lucassen
|
View ↗ |
| 17 Mar 2026 |
Oral evidence session
Professor Florian Markowetz,
Rich Scott · Genomics England
|
View ↗ |
| 10 Mar 2026 |
Oral evidence session
Dr Robert Goldstone,
Professor Ewan Birney,
Professor Sir Mark Caulfield
|
View ↗ |
Who gave evidence
On smaller screens, scroll horizontally to read every column. Keyboard users can focus the table region and use the arrow keys.
| Witness | Organisation | Sessions |
|---|---|---|
| Chris Molloy · CEO | Medicines Discovery Catapult | 1 |
| Dr Bernie Croal · President | The Royal College of Pathologists | 1 |
| Dr Christian Itin · Chief Executive Officer | Autolus Therapeutics | 1 |
| Dr Melanie Ivarsson · Chief Executive Officer | Health Data Research Service (HDRS) | 1 |
| Dr Michalis Papadakis · Chief Executive Officer and Co-Founder | Brainomix | 1 |
| Dr Phil L'Huillier · Chief Executive Officer | Scancell | 1 |
| Dr Pritesh Mistry · Fellow, Digital Technologies | The Kings Fund | 1 |
| Dr Robert Goldstone | Not recorded | 1 |
| Dr Stephen Harden · President | The Royal College of Radiologists (RCR) | 1 |
| Dr Valerie Crolley · Medical oncology consultant | Royal Free NHS Foundation Trust | 1 |
| Fiona Bride · Interim Director General for Commercial and Growth | Department of Health and Social Care (DHSC) | 1 |
| Lawrence Tallon · CEO | Medicines and Healthcare products Regulatory Agency (MHRA) | 1 |
| Matthew Durdy · CEO | Cell and Gene Therapy Catapult | 1 |
| Preet Kaur Gill MP · Parliamentary Under-Secretary of State for Health Innovation and Safety | Department of Health and Social Care (DHSC) | 1 |
| Professor Andrew Beggs · Professor of Cancer Genetics and Surgery | University of Birmingham | 1 |
| Professor Andrew Morris | Not recorded | 1 |
| Professor Anneke Lucassen | Not recorded | 1 |
| Professor Ben Bridgewater · Executive Chair | Health Innovation Network | 1 |
| Professor Cathie Sudlow | Not recorded | 1 |
| Professor Dame Sue Hill | Not recorded | 1 |
| Professor Ewan Birney | Not recorded | 1 |
| Professor Florian Markowetz | Not recorded | 1 |
| Professor Jonathan Benger CBE · Chief Executive Officer | NICE (National Institute for Health and Care Excellence) | 1 |
| Professor Mikael Sodergren · Clinical Associate Professor | Imperial College London | 1 |
| Professor Nick Turner · Director of Clinical Research and Development | The Royal Marsden NHS Foundation Trust | 1 |
| Professor Peter Donnelly · Chief Executive Officer | Genomics Ltd | 1 |
| Professor Raghib Ali OBE · CEO, Chief Investigator and Chief Medical Officer | Our Future Health | 1 |
| Professor Sir Mark Caulfield | Not recorded | 1 |
| Professor Sir Rory Collins FRS, FMedSci, FRCP · Chief Executive | UK Biobank | 1 |
| Rich Scott · CEO | Genomics England | 1 |
| Rob Thompson · Chief Digital, Data and Technology Officer | Department of Health and Social Care (DHSC) | 1 |
| Roland Sinker CBE · Former CEO | Cambridge University Hospitals Trust (2015-2025) | 1 |
| The Baroness Blackwood of North Oxford · Chair | Health Data Research Service (HDRS) | 1 |